Status:
UNKNOWN
Molecular Markers in Cervical Cancer Screening in the Feasibility of the Mathematical Markov Model Analysis
Lead Sponsor:
Wuhan University
Conditions:
Cervical Cancer
Eligibility:
FEMALE
25-65 years
Brief Summary
The purpose of this study is to: 1. make p16INK4A as a cervical cancer screening of tumor markers, cytology improve existing diagnostic sensitivity, specificity, repeatability and validity, so as to ...
Detailed Description
1. To carry out large-scale prospective randomized controlled clinical study to evaluate the "cytological molecular markers Detect + P16INK4A" methods of screening accuracy and reliability, as well as...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Married women aged 25 to 65-year-old with risk factors
- No tumor and pelvic radiation therapy history
- Non-pregnant women at present
Exclusion
Key Trial Info
Start Date :
April 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 1 2011
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT00889902
Start Date
April 1 2009
End Date
July 1 2011
Last Update
April 29 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
People'S Hospital
Wufeng County, Hubei, China